Approval · Notice of Compliance 35894 · 2025
PONVORY: Notice of Compliance 35894
Issued August 25, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35894
- Date
- August 25, 2025
- Company
- Vanda Pharmaceuticals Inc.Washington, District Of Columbia, United States
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in product ownership